EVALUATION OF NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-ACTIVITY INVIVO IN PATIENTS TREATED WITH HIGH-DOSE INTERLEUKIN-2 AND ADOPTIVE TRANSFER OF AUTOLOGOUS LAK CELLS

被引:17
|
作者
WALEWSKI, J
PAIETTA, E
DUTCHER, J
WIERNIK, PH
机构
[1] MONTEFIORE MED CTR,DEPT ONCOL,111 E 210TH ST,BRONX,NY 10467
[2] ALBERT EINSTEIN MED CTR,DEPT MED,BRONX,NY 10467
关键词
D O I
10.1007/BF00397919
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:170 / 174
页数:5
相关论文
共 50 条
  • [1] GENERATION OF LYMPHOKINE-ACTIVATED KILLER (LAK) ACTIVITY INVIVO WITH RECOMBINANT INTERLEUKIN-2
    THOMPSON, JA
    CHEEVER, MA
    KERN, DE
    GREENBERG, PD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 318 - 318
  • [2] LYMPHOKINE-ACTIVATED KILLER (LAK) AND NATURAL-KILLER (NK) CELL-ACTIVITY IN HUMAN INTESTINAL-MUCOSA
    HOGAN, PG
    HAPEL, AJ
    DOE, WF
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1985, 15 (04): : 563 - 563
  • [3] THERAPEUTIC USES OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
    RICHARDS, JM
    BLOOD REVIEWS, 1989, 3 (02) : 110 - 119
  • [4] REGIONAL ADOPTIVE IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS FOR LIVER METASTASES
    KEILHOLZ, U
    SCHEIBENBOGEN, C
    BRADO, M
    GEORGI, P
    MACLACHLAN, D
    BRADO, B
    HUNSTEIN, W
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (01) : 103 - 105
  • [5] LYMPHOKINE-ACTIVATED KILLER (LAK) AND NATURAL-KILLER (NK) CELL-ACTIVITY AGAINST HUMAN MELANOCYTES AND MALIGNANT-MELANOMA CELLS
    DURHAMPIERRE, DG
    HALDER, RM
    PHAM, HN
    ROSSER, S
    WALTERS, CS
    CLINICAL RESEARCH, 1989, 37 (02): : A717 - A717
  • [6] LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-ACTIVITY AGAINST AUTOLOGOUS MONOCYTES IN CANCER-PATIENTS
    DJEU, JY
    SERBOURSEK, D
    LYMAN, GH
    KAVANAGH, JJ
    NICOLETTO, JP
    BLANCHARD, DK
    FASEB JOURNAL, 1988, 2 (04): : A688 - A688
  • [7] LYMPHOKINE-ACTIVATED KILLER (LAK) AND NATURAL-KILLER (NK) CELL-ACTIVITY AGAINST HUMAN MELANOCYTES AND MALIGNANT-MELANOMA CELLS
    DURHAMPIERRE, DG
    HALDER, RM
    PHAM, HN
    ROSSER, S
    WALTERS, CS
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (03) : 422 - 422
  • [8] INHIBITION OF MURINE LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-ACTIVITY BY ADHERENT CELLS
    LONGLEY, RE
    STEWART, D
    ROE, KG
    GOOD, RA
    CELLULAR IMMUNOLOGY, 1989, 121 (02) : 225 - 236
  • [9] AN ADOPTIVE IMMUNOTHERAPY OF PATIENTS WITH MEDULLOBLASTOMA BY LYMPHOKINE-ACTIVATED KILLER CELLS (LAK)
    OKAMOTO, Y
    SHIMIZU, K
    TAMURA, K
    MIYAO, Y
    YAMADA, M
    MATSUI, Y
    TSUDA, N
    TAKIMOTO, H
    HAYAKAWA, T
    MOGAMI, H
    ACTA NEUROCHIRURGICA, 1988, 94 (1-2) : 47 - 52
  • [10] THE ROLE OF EOSINOPHILS IN INTERLEUKIN-2/LYMPHOKINE-ACTIVATED KILLER (LAK) CELL THERAPY
    ISHIMITSU, T
    IWASAKI, K
    TORISU, M
    FASEB JOURNAL, 1992, 6 (04): : A1152 - A1152